Patents by Inventor Michael Hanna, Jr.

Michael Hanna, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor specific monoclonal antibodies
    Patent number: 5180814
    Abstract: A human monoclonal antibody having specificity for an epitope in a tumor associated antigen, said antibody produced by a cell line selected from the group consisting of Co6a3-1 (HB8493), Co7a4 (HB8494), Co28A32 (HB9380), Co16-86 (HB8496), and Co16-88 (HB8495).
    Type: Grant
    Filed: January 22, 1991
    Date of Patent: January 19, 1993
    Assignee: Akzo N.V.
    Inventors: Michael Hanna, Jr., Martin V. Haspel, Herbert C. Hoover, Jr.
  • Tumor associated monocoloal antibodies derived from human B-cell line
    Patent number: 4997762
    Abstract: Hybridoma cell lines and transformed B-cell lines are derived from B-cells of cancer patients actively immunized with autologous tumor antigens and used to produce monoclonal antibodies having specificity for tumor-associated antigens. The monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers.
    Type: Grant
    Filed: April 15, 1987
    Date of Patent: March 5, 1991
    Assignee: Akzo N.V.
    Inventors: Michael Hanna, Jr., Martin V. Haspel, Herbert C. Hoover, Jr.
  • Tumor specific monoclonal antibodies
    Patent number: 4828991
    Abstract: Monoclonal antibodies produced by hybridoma or transformed B-cell lines deriveed from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers.
    Type: Grant
    Filed: January 31, 1985
    Date of Patent: May 9, 1989
    Assignee: Akzo N.V.
    Inventors: Michael Hanna, Jr., Martin V. Haspel, Herbert C. Hoover, Jr.